{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:41:26Z","timestamp":1787049686759,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ahj.2018.09.001","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:28:19Z","timestamp":1536704899000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention"],"prefix":"10.1016","volume":"207","author":[{"given":"Paul","family":"Guedeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimmer","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Camaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabato","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Faggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah N.","family":"Kalkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Barman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srushthi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25 Suppl. 2","key":"10.1016\/j.ahj.2018.09.001_bb0005","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ahj.2018.09.001_bb0010","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.jacc.2017.03.585","article-title":"Trends in use of high-intensity statin therapy after myocardial infarction, 2011 to 2014","volume":"69","author":"Rosenson","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.09.001_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2016.07.024","article-title":"Impact of the 2013 American College of Cardiology\/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke","volume":"181","author":"Valentino","year":"2016","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.001_bb0020","first-page":"892","article-title":"Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC\/AHA guideline on the treatment of blood cholesterol","volume":"22","author":"Bellows","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"10.1016\/j.ahj.2018.09.001_bb0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacl.2015.11.002","article-title":"Provider understanding of the 2013 ACC\/AHA cholesterol guideline","volume":"10","author":"Virani","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ahj.2018.09.001_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ahj.2017.08.005","article-title":"Lipid management in contemporary community practice: results from the Provider Assessment of Lipid Management (PALM) Registry","volume":"193","author":"Navar","year":"2017","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.ahj.2018.09.001_bb0035","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2018.09.001_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/clc.22641","article-title":"Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and\/or diabetes mellitus in 2014: insights from a large US managed-care population","volume":"40","author":"Steen","year":"2017","journal-title":"Clin Cardiol"},{"issue":"15","key":"10.1016\/j.ahj.2018.09.001_bb0045","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000035649.39669.CE","article-title":"Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)","volume":"106","author":"Mukherjee","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ahj.2018.09.001_bb0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.ahj.2018.09.001_bb0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"issue":"9753","key":"10.1016\/j.ahj.2018.09.001_bb0060","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ahj.2018.09.001_bb0065","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z Trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.ahj.2018.09.001_bb0070","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahj.2018.09.001_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamacardio.2016.4052","article-title":"Association between intensity of statin therapy and mortality in patients with atherosclerotic cardiovascular disease","volume":"2","author":"Rodriguez","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.001_bb0080","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jacc.2005.03.077","article-title":"Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial","volume":"46","author":"Ray","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.001_bb0085","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2005.11.031","article-title":"Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese","volume":"97","author":"Sakamoto","year":"2006","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2018.09.001_bb0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCULATIONAHA.113.002658","article-title":"Racial\/ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction","volume":"129","author":"Lauffenburger","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ahj.2018.09.001_bb0095","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.amjcard.2015.02.052","article-title":"Antiplatelet and statin use in us patients with coronary artery disease categorized by race\/ethnicity and gender, 2003 to 2012","volume":"115","author":"Johansen","year":"2015","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ahj.2018.09.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005449","article-title":"Vulnerabilities to health disparities and statin use in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study","volume":"6","author":"Schroff","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.09.001_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijcard.2015.11.164","article-title":"No evidence to support high-intensity statin in Chinese patients with coronary heart disease","volume":"204","author":"Dai","year":"2016","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2018.09.001_bb0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ahj.2018.09.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004264","article-title":"Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the Reasons for Geographic and Racial Differences in Stroke Study","volume":"6","author":"Gamboa","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.ahj.2018.09.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005523","article-title":"Age and sex disparities in discharge statin prescribing in the stroke belt: evidence from the Reasons for Geographic and Racial Differences in Stroke Study","volume":"6","author":"Albright","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"16","key":"10.1016\/j.ahj.2018.09.001_bb0125","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","article-title":"Sex differences in high-intensity statin use following myocardial infarction in the United States","volume":"71","author":"Peters","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2018.09.001_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.09.012","article-title":"Sex differences in lipid profiles and treatment utilization among young adults with acute myocardial infarction: results from the VIRGO study","volume":"183","author":"Lu","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2018.09.001_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ahj.2016.09.007","article-title":"Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: practice impact of the new cholesterol guidelines","volume":"182","author":"Rodriguez","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2018.09.001_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2017.06.005","article-title":"Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol","volume":"191","author":"Wei","year":"2017","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2018.09.001_bb0145","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2018.09.001_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcin.2017.11.020","article-title":"Effect of increasing stent length on 3-year clinical outcomes in women undergoing percutaneous coronary intervention with new-generation drug-eluting stents: patient-level pooled analysis of randomized trials from the WIN-DES Initiative","volume":"11","author":"Chandrasekhar","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.ahj.2018.09.001_bb0155","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.09.001_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2015.11.014","article-title":"Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease","volume":"173","author":"O'Brien","year":"2016","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318302692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:01:28Z","timestamp":1757570488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318302692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"alternative-id":["S0002870318302692"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.09.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}